It was recently confirmed by Nintendo that it is exiting its X integration because of the high API fees that the platform is charging them, marking the day it will be over. However, there seems to be ...
Novo Nordisk received FDA approval for oral Wegovy, but unit economics are structurally unfavorable due to poor bioavailability and high API requirements. I cut my rating to Sell (market underperform) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback